ZYBERNO
Stock Report
Updated Jun 10, 2026

America Great Health (AAGH)

Healthcare • Over The Counter

$0.00

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
America Great Health (AAGH) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-71.8%)
Return on Capital (Capital Efficiency):CRITICAL (-111.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

America Great Health (AAGH) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, AAGH generated -$615.63K in Owner Earnings.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.00
Market Cap:$2.12M

Valuation Multiples (2)

P/S Ratio:4.82x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$3.59M
B. Profitability Assessment

Margin Analysis (3)

Operating Margin Ttm:-71.8%
Net Margin Ttm:-150.1%
Ebitda Margin:-68.5%

TTM Performance (3)

Gross Margin Ttm:73.5%
Operating Margin Ttm:-71.8%
Net Margin Ttm:-150.1%

Yield Metrics (2)

Earnings Yield:$0.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):46.4%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.05x
Quick Ratio:0.01x
Cash Ratio:0.01x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-0.31x
Times Interest Earned:-0.31

Capital Structure (4)

Working Capital:-3,593,960.00
Cash And Cash Equivalents:28,079.00
Long Term Debt:$0.00
Net Debt:$1.47M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $439.18K
Linear Growth: 46.4%
📊 Click to view full AAGH Revenue analysis & methodology →
Cost Of Revenue Ttm:$116.17K

Profitability Breakdown (2)

Gross profit TTM: $323.01K
Linear Growth: 100.0%
📊 Click to view full AAGH Gross Profit analysis & methodology →
-$315.46K

Bottom Line Performance (3)

-$659.08K
Income Before Tax:-$659.64K
Ebitda Ttm:-300,671.00

Operating Expenses (5)

Operating Expenses:20,812.00
R And D Expense:0.00
Sga Expense:638,469.00
Income Tax Expense:$800.00
Interest Expense:1,230,485.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:340.4%
Ebitda Margin:-68.5%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$241.30K
Current Assets:$185.05K
Ppe Net:24,417.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:6,070,405.00
Current Liabilities:3,779,008.00
Long Term Debt:$0.00
Short Term Debt:$1.50M

Equity & Capital (3)

Equity:-$5.83M
Retained Earnings:-$10.87M
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:137,874.00
Accounts Payable:1,502,651.00

Special Items (2)

Contract Liabilities:8,236.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$192.82K-$615.63K

Investment Activities (2)

Investing Cash Flow:$0.00
Capital Expenditures Ttm:0.00

Financing Activities (3)

Financing Cash Flow:-$60.52K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$1.32M
Long Term Debt Repayments:$10.00K

Non-Cash Items (1)

Depreciation Amortization Ttm:14,789.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):0.00
$0.00
Earnings Per Share Ttm:-$0.00

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.00
Operating Cash Flow Per Share:-$0.00

Book Value & Capital (2)

Book Value Per Share:-$0.00
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.61x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:0.84x
Days Inventory Outstanding Ttm:433.20

Payables & Cash Cycle (2)

Days Payable Outstanding:4,721.37
Cash Conversion Cycle:-5,287.17
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$615.63K
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):46.4%

Other Growth Rates (1)

Gross Profit Growth Rate (Linear):100.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:AAGH
Company Name:America Great Health
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:Over The Counter
Country:Unknown

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:21.15B
Shares Outstanding Basic:21.15B
Shares Outstanding Diluted:21.14B

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-06-10 17:54:43 UTC
Data Timestamp:2026-06-10T17:54:43.425967
Scroll to Top